The Magazine for Sleep Professionals
Wednesday, September 16, 2026
HoneyNaps, specializing in AI-powered sleep medical devices, has developed a next-generation wireless polysomnography system that combines patch-based skin sensors with artificial intelligence-driven analysis. Polysomnography (PSG) is the standard diagnostic test for sleep disorders such as sleep apnea. Conventional PSG, however, generally requires patients to spend a night at a hospital […]
A novel AI model can use information collected during routine sleep studies to identify patients’ long-term health risks, according to a new study published in Nature Communications. Developed by a multidisciplinary research team, the model uncovered hidden sleep patterns linked to risks including heart disease, cognitive decline and death. The […]
Researchers from Universidad Carlos III de Madrid (UC3M) and Hospital Universitario Severo Ochoa in Leganés, part of the public health network of the Comunidad de Madrid, have developed a methodology that uses artificial intelligence (AI) to analyze brain electrical activity during sleep and facilitate the early diagnosis of Alzheimer’s. The […]
Healthcare providers are under growing pressure to improve patient access while facing staffing shortages and rising operational costs. Yet, many AI tools fail to deliver measurable financial results, leaving practices stuck in “pilot purgatory.” Patient Prism aims to solve these challenges with its AI Revenue Activation platform. The proprietary AI-driven […]
HoneyNaps, an AI-based sleep medicine company, announced that SOMNUM V3.0, its AI diagnosis software for polysomnography (PSG) analysis, has received U.S. Food and Drug Administration (FDA) clearance under clearance number K253390. SOMNUM is clinical decision support software designed to assist medical professionals in analyzing PSG data, including sleep staging and […]
sovaSage™ announced the new release of Clinical Indicator Intelligence™, an enhanced feature within sovaGuide™ featuring Jeanie™. Using machine learning, the new capability continuously analyzes multiple PAP therapy variables to help providers identify patients who may require additional clinical evaluation before therapy challenges lead to reduced benefit or treatment abandonment. The […]
Ognomy Sleep, announced the closing of a $20 million Series A financing round led by Catalyst Investors, with participation from Blue Heron Capital. The round also included new and follow-on investments from Impellent Ventures, LaunchNY, Excell and Upstate Biotech Ventures, University of Buffalo, and strategic partners who have supported the company’s […]
Here’s an uncomfortable exercise. Tomorrow morning, walk through your sleep lab or practice and ask one question: “Has anyone here ever used ChatGPT, Claude, Gemini, or another AI tool for work?” If the answer is no, chances are someone isn’t being completely honest. Artificial intelligence has become part of the […]
Sleep.ai announced findings from a peer-reviewed study led by Washington State University, in collaboration with the University of Washington, exploring sleep patterns in people with chronic insomnia. It is the longest known objective, real-world characterization of objective sleep in chronic insomnia. Published in JMIR Formative Research, the study tracked 112 adults […]
University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery that could dramatically accelerate the creation of new medicines. UVA’s Nikolay V. Dokholyan, PhD, and colleagues have developed a suite of artificial intelligence-powered tools, called YuelDesign, YuelPocket and YuelBond, that work together to […]
